AngioDynamics, Inc.

ANGO Healthcare Medical Instruments & Supplies

AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025. In the quarter to August 2026, revenue grew 6.87%, EPS grew 35.0% and free cash flow grew 5.62%, each against the same quarter a year earlier.

11.25 0.33 −2.85%
Market cap
$487.0M
P/E
0.0×
Fwd P/E
−20.7×
Dividend yield
—
F-score
5/9
Altman Z
1.63
Beneish M
−3.08
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

May '26 May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17
Total current assets
163.39 168.32 193.25 163.54 143.35 140.88 152.91 315.29 168.03 153.91
Total non-current assets
103.77 111.82 124.42 369.10 409.41 420.56 441.30 521.15 537.44 554.05
Total Assets
267.16 280.14 317.67 532.64 552.75 561.44 594.21 836.44 705.47 707.96
Total current liabilities
74.72 76.20 91.16 83.83 74.32 57.58 51.45 73.30 57.30 71.52
Total non-current liabilities
21.62 20.98 20.93 70.52 53.94 64.40 87.90 148.32 105.58 121.42
Total liabilities
96.34 97.17 112.09 154.34 128.26 121.98 139.34 221.62 162.88 192.93
Common Equity (Total)
170.83 182.97 205.59 378.30 424.49 439.46 454.87 614.82 542.60 515.03
Shareholders Equity (Total)
170.83 182.97 205.59 378.30 424.49 439.46 454.87 614.82 542.60 515.03
Total Debt
— — — 49.82 25.00 20.00 40.00 131.91 91.62 96.32

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 13 Oct 2026